Harriet L Robinson

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 4 EPO patents. Top assignees: Geovax, Inc., Emory University, University of Massachusetts. Active years: 1997-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harriet L Robinson. Retrieved from https://idiyas.com/inventor/harriet-l-robinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 73.7

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 171(Granted Patents)

Location History:

Southborough, MA (US) (1997 - 2000)
Southboro, MA (US) (1997 - 2005)
Atlanta, GA (US) (2010 - 2023)
Palo Alto, CA (US) (2021 - 2024)

Company Filing History:

University of Massachusetts

patents

4. 3 out of 281

St. Jude Children's Research Hospital

patents

5. 3 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 1

National Institute of Allergy and Infectious Diseases (Niaid)

patent

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370249 - Replication-deficient modified vaccinia ankara (MVA) expressing marburg virus glycoprotein (GP) and matrix protein (VP40) (2025-07-29),

2. 12247214 - Vaccinia viral vectors encoding chimeric virus like particles (2025-03-11),

3. 11897919 - Multivalent HIV vaccine boost compositions and methods of use (2024-02-13),

4. 11896657 - Replication-deficient modified vaccinia Ankara (MVA) expressingglycoprotein (GP) and matrix protein (VP40) (2024-02-13),

5. 11701418 - Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40) (2023-07-18),

6. 11413341 - Vaccinia viral vectors encoding chimeric virus like particles (2022-08-16),

7. 11278607 - Compositions and methods for generating an immune response to a tumor associated antigen (2022-03-22),

8. 11098086 - Multivalent HIV vaccine boost compositions and methods of use (2021-08-24),

9. 9453239 - Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes (2016-09-27),

10. 9254319 - Compositions and methods for generating an immune response (2016-02-09),

11. 8916172 - MVA expressing modified HIV envelope, gag, and pol genes (2014-12-23),

12. 8623379 - Compositions and methods for generating an immune response (2014-01-07),

13. 7867982 - MVA expressing modified HIV envelope, gag, and pol genes (2011-01-11),

14. 7850956 - Immunization by inoculation of DNA transcription unit (2010-12-14),

15. 7795017 - DNA expression vectors and methods of use (2010-09-14),

Title: Harriet L Robinson: Pioneering Inventor from Atlanta

Introduction: Harriet L Robinson is a trailblazing inventor based in Atlanta, Georgia, known for her innovative contributions to various fields.

Latest Patents: Harriet L Robinson holds several patents in the areas of sustainable energy solutions, eco-friendly packaging, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Harriet L Robinson has been recognized for her groundbreaking work in developing cutting-edge technologies that have positively impacted industries worldwide.

Collaborations: Throughout her career, Harriet L Robinson has collaborated with leading research institutions, universities, and companies to further enhance the impact of her inventions and bring them to the market successfully.

Conclusion: Harriet L Robinson's dedication to innovation and her passion for creating solutions to real-world problems make her a true pioneer in the field of inventing, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.